Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings

FDA-cleared Optive AI software is positioned to enhance the Swoop system’s image quality, clinical utility, ease of use, and isotropic imaging capability. The update is likely supportive for the product offering, but no financial figures, guidance, or adoption metrics were provided.

Analysis

FDA-cleared Optive AI software is positioned to enhance the Swoop system’s image quality, clinical utility, ease of use, and isotropic imaging capability. The update is likely supportive for the product offering, but no financial figures, guidance, or adoption metrics were provided.